Search results
Here’s why ImmunityBio (IBRX) stock price surged and what next | Invezz
Invezz· 13 hours agoThis rally makes ImmunityBio one of the best-performing stocks in ...Street as it has risen by over...
3 big changes coming to Medicare in 2025—and what they’ll mean for you
Fortune via Yahoo Finance· 20 hours agoThe new rule also says it will stop brokers and agents from receiving “administrative fees” above...
Does Neurocrine, The No. 1 Biotech Stock, Have The Next Ketamine On Its Hands?
Investor's Business Daily· 57 minutes agoTop-notch biotech stock Neurocrine Biosciences surged Tuesday after analysts suggested the company's...
Why is 1st drug shown to slow Alzheimer’s off to a slow start? | Times News Online
Times News· 6 hours agoThe first drug shown to slow Alzheimer’s disease hit the U.S. market over a year ago, but sales have...
AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 7 hours agoThe upfront cash and CV payment add up to a total transaction value of approximately $2.4 billion....
Novartis Stock Jumps After Beating Expectations, Raising Guidance
The Wall Street Journal· 5 hours agoShares of Swiss drugmaker Novartis rallied after the company’s first-quarter sales surpassed...
Health Care Roundup: Market Talk
The Wall Street Journal· 4 hours agoNovartis reported a solid sales growth of its key drugs and doesn’t see generics competition for Promacta—a drug for blood disorders—in 2024, the analyst...
Drugmaker Novartis climbs 4.4% after guidance rise on sales of blockbuster drugs
CNBC· 13 hours agoNovartis' net sales rose 11% in the...income increased 22% over the same period. CEO Vas Narasimhan...
Coming FDA Approvals Could Send These 3 Drug Stocks Soaring
InvestorPlace· 6 days agoIn the biotech and pharmaceutical world, FDA approval is the number one needle mover for drug...
Better Buy: Pfizer vs. Viking Therapeutics
Motley Fool via Yahoo Finance· 8 hours agoOn the bright side, Pfizer's strategic decision to avoid major revenue shortfalls by aiming to bring large numbers of drugs to market safeguards its...
